Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
Open Access
- 21 June 2023
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 13 (1) , 1-11
Abstract
We have recently reported alterations in the plasma concentrations of lysophosphatidic acid (LPA) in patients with substance use disorders. In order to further explore the potential role of the LPA signaling system as biomarker in cocaine use disorders (CUD) we conducted a cross-sectional study with 105 patients diagnosed with CUD and 92 healthy controls. Participants were clinically evaluated and blood samples were collected to determine plasma concentrations of total LPA and LPA species (16:0-, 18:0-, 18:1-, 18:2-, and 20:4-LPA), and the gene expression of LPA1 and LPA2 receptors in peripheral blood mononuclear cells. We found that patients with CUD had significantly lower plasma concentration of the majority of LPA species, while the mRNA expression of LPA1 receptor was found to be higher than controls. Moreover, we found a positive association between plasma concentration of 20:4-LPA and relevant CUD-related variables: age of onset cocaine use and length of cocaine abstinence. The statistical analysis revealed sex differences in concentrations of total LPA and LPA species, and women showed higher LPA concentrations than men. Furthermore, studies in rats of both sexes showed that plasma concentrations of total LPA were also altered after acute and chronic cocaine administration, revealing a sexual dimorphism in these effects. This study found alterations on the LPA signaling system in both, patients with CUD and rats treated with cocaine. Our results demonstrate that LPA signaling is impacted by CUD and sex, which must be taken into consideration in future studies evaluating LPA as a reliable biomarker for CUD.Keywords
Funding Information
- Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI20/01399, CPII19/00031, RD21/0009/0003, PI19/01577)
- Consejería de Salud, Junta de Andalucía (PI-0140-2018)
- Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (UMA18-FEDERJA-059)
This publication has 46 references indexed in Scilit:
- Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidityAddiction Biology, 2013
- Lysophospholipids and their receptors in the central nervous systemBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2013
- Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Drug and Alcohol Dependence, 2011
- LPA Receptors: Subtypes and Biological ActionsAnnual Review of Pharmacology and Toxicology, 2010
- Two pathways for lysophosphatidic acid productionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Diagnosing Comorbid Psychiatric Disorders in Substance Abusers: Validity of the Spanish Versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IVAmerican Journal of Psychiatry, 2004
- Direct Quantitative Analysis of Lysophosphatidic Acid Molecular Species by Stable Isotope Dilution Electrospray Ionization Liquid Chromatography–Mass SpectrometryAnalytical Biochemistry, 2001
- Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA speciesFEBS Letters, 2000
- Essential fatty acids are mediators of brain biochemistry and cognitive functionsJournal of Neuroscience Research, 1999
- The Composite International Diagnostic InterviewArchives of General Psychiatry, 1988